Fleur M. van der Valk

2.1k citations

24 papers · 1.6k indexed · 1 hit paper · h-index 20

Surgery top 5%
Immunology top 5%
Cardiology and Cardiovascular Medicine top 5%
Molecular Biology
Endocrinology, Diabetes and Metabolism top 5%

Co-authors: Erik S.G. Stroes Hein J. Verberne Aart J. Nederveen Jeffrey Kroon Max Nieuwdorp Jan Van den Bossche Simone L. Verweij Jaap D. van Buul
Topics: Atherosclerosis and Cardiovascular Diseases (14 papers)Lipoproteins and Cardiovascular Health (9 papers)Adipokines, Inflammation, and Metabolic Diseases (6 papers)
Cited by: Immunology Surgery Endocrinology, Diabetes and Metabolism
Journals: Circulation Journal of the American College of Cardiology Journal of the American Society of Nephrology
Partner nations: Netherlands United States Germany

In The Last Decade

Fleur M. van der Valk

24 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans

2016 454 citations Fleur M. van der Valk, Siroon Bekkering et al. Circulation profile →

Peers

Countries citing papers authored by Fleur M. van der Valk

Since Specialization

Citations

This map shows the geographic impact of Fleur M. van der Valk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fleur M. van der Valk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fleur M. van der Valk more than expected).

Fields of papers citing papers by Fleur M. van der Valk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fleur M. van der Valk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fleur M. van der Valk. The network helps show where Fleur M. van der Valk may publish in the future.

Co-authorship network of co-authors of Fleur M. van der Valk

This figure shows the co-authorship network connecting the top 25 collaborators of Fleur M. van der Valk. A scholar is included among the top collaborators of Fleur M. van der Valk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fleur M. van der Valk. Fleur M. van der Valk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Methods for quantifying adipose tissue insulin resistance in overweight/obese humans 2017 ·International Journal of Obesity ·Kasper W. ter Horst,Katy A. van Galen,Pim W. Gilijamse,Annick V. Hartstra,Pieter F. de Groot,Fleur M. van der Valk,Mariëtte T. Ackermans,Max Nieuwdorp,Johannes A. Romijn,Mireille J. Serlie	55
2	Oxidized phospholipids on lipoprotein(a) induce epigenetic reprogramming and an increased pro-atherogenic response in human monocytes 2017 ·Atherosclerosis ·Renate M. Hoogeveen,Fleur M. van der Valk,Jeffrey Kroon,(unknown),(unknown),Jaap D. van Buul,Corey A. Scipione,Max Nieuwdorp,Leo A. B. Joosten,Mihai G. Netea,Marlys L. Koschinsky,(unknown),Sotirios Tsimikas,Niels P. Riksen,Erik S.G. Stroes,Siroon Bekkering	1
3	Increased arterial wall inflammation in patients with ankylosing spondylitis is reduced by statin therapy 2016 ·Annals of the Rheumatic Diseases ·Fleur M. van der Valk,Sophie J. Bernelot Moens,Simone L. Verweij,Aart C. Strang,Aart J. Nederveen,Hein J. Verberne,Michael T. Nurmohamed,Dominique Baeten,Erik S.G. Stroes	24
4	Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humansbreakdown → 2016 ·Circulation ·Fleur M. van der Valk,Siroon Bekkering,Jeffrey Kroon,Calvin Yeang,Jan Van den Bossche,Jaap D. van Buul,Amir Ravandi,Aart J. Nederveen,Hein J. Verberne,Corey A. Scipione,Max Nieuwdorp,Leo A. B. Joosten,Mihai G. Netea,Marlys L. Koschinsky,Joseph L. Witztum,Sotirios Tsimikas,Niels P. Riksen,Erik S.G. Stroes	454
5	HDL mimetic CER-001 targets atherosclerotic plaques in patients 2016 ·Atherosclerosis ·Kang H. Zheng,Fleur M. van der Valk,Loek P. Smits,(unknown),Jean‐Louis Dasseux,Rudi Baron,Ronald Barbaras,Constance Keyserling,Bram F. Coolen,Aart J. Nederveen,Hein J. Verberne,(unknown),Daniëlle J. Vugts,Raphaël Duivenvoorden,Zahi A. Fayad,Willem J. M. Mulder,Guus A.M.S. van Dongen,Erik S.G. Stroes	52
6	Thresholds for Arterial Wall Inflammation Quantified by 18F-FDG PET Imaging 2016 ·JACC. Cardiovascular imaging ·Fleur M. van der Valk,Simone L. Verweij,Koos Zwinderman,Aart C. Strang,Yannick Kaiser,Henk A. Marquering,Aart J. Nederveen,Erik S.G. Stroes,Hein J. Verberne,James H.F. Rudd	75
7	Increased haematopoietic activity in patients with atherosclerosis 2016 ·European Heart Journal ·Fleur M. van der Valk,Carlijn Kuijk,Simone L. Verweij,Lotte C.A. Stiekema,Yannick Kaiser,Sacha Zeerleder,Matthias Nahrendorf,Carlijn Voermans,Erik S.G. Stroes	74
8	Carotid arterial wall inflammation in peripheral artery disease is augmented by type 2 diabetes: a cross-sectional study 2016 ·BMC Cardiovascular Disorders ·Sophie J. Bernelot Moens,Robert M. Stoekenbroek,Fleur M. van der Valk,Simone L. Verweij,Mark J.W. Koelemay,Hein J. Verberne,Max Nieuwdorp,Erik S.G. Stroes	6
9	Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study 2016 ·Arthritis Research & Therapy ·Sophie J. Bernelot Moens,Fleur M. van der Valk,Aart C. Strang,Jeffrey Kroon,Loek P. Smits,E. Kneepkens,Hein J. Verberne,Jaap D. van Buul,Michael T. Nurmohamed,Erik S.G. Stroes	30
10	Liposomal prednisolone promotes macrophage lipotoxicity in experimental atherosclerosis 2016 ·Nanomedicine Nanotechnology Biology and Medicine ·Fleur M. van der Valk,Dominik M. Schulte,Svenja Meiler,Jun Tang,Kang H. Zheng,Jan Van den Bossche,Tom Seijkens,Matthias Laudes,Menno P.J. de Winther,Esther Lutgens,Amr Alaarg,Josbert M. Metselaar,Geesje M. Dallinga‐Thie,Willem J. M. Mulder,Erik S.G. Stroes,Anouk A.J. Hamers	31
11	Multiple pathway assessment to predict anti-atherogenic efficacy of drugs targeting macrophages in atherosclerotic plaques 2016 ·Vascular Pharmacology ·Amr Alaarg,Kang H. Zheng,Fleur M. van der Valk,(unknown),Miranda Versloot,(unknown),Dominik M. Schulte,Gert Storm,Josbert M. Metselaar,Erik S.G. Stroes,Anouk A.J. Hamers	9
12	Current therapies for lowering lipoprotein (a) 2015 ·Journal of Lipid Research ·Julian C. van Capelleveen,Fleur M. van der Valk,(unknown)	74
13	Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy 2015 ·Nanomedicine Nanotechnology Biology and Medicine ·Mark E. Lobatto,Claudia Calcagno,Maarten J. Otten,Antoine Millon,Sarayu Ramachandran,(unknown),Fleur M. van der Valk,Gert Storm,(unknown),(unknown),Willem J. M. Mulder,Josbert M. Metselaar	36
14	Novel directions in inflammation as a therapeutic target in atherosclerosis 2015 ·Current Opinion in Lipidology ·Simone L. Verweij,Fleur M. van der Valk,Erik S.G. Stroes	22
15	Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA 2015 ·Journal of Lipid Research ·Ruud S. Kootte,Loek P. Smits,Fleur M. van der Valk,Jean‐Louis Dasseux,Constance Keyserling,Ronald Barbaras,John F. Paolini,Raúl D. Santos,Theo H. van Dijk,(unknown),Aart J. Nederveen,Willem J. M. Mulder,G. Kees Hovingh,(unknown),Albert K. Groen,(unknown)	75
16	Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration 2015 ·Nanomedicine Nanotechnology Biology and Medicine ·Fleur M. van der Valk,Diederik F. van Wijk,Mark E. Lobatto,Hein J. Verberne,Gert Storm,M.C. Willems,D.A. Legemate,Aart J. Nederveen,Claudia Calcagno,Venkatesh Mani,Sarayu Ramachandran,(unknown),Maarten J. Otten,Geesje M. Dallinga‐Thie,Zahi A. Fayad,Max Nieuwdorp,Dominik M. Schulte,Josbert M. Metselaar,Willem J. M. Mulder,Erik S.G. Stroes	128
17	Increased Systemic and Plaque Inflammation in ABCA1 Mutation Carriers With Attenuation by Statins 2015 ·Arteriosclerosis Thrombosis and Vascular Biology ·Andrea E. Bochem,Fleur M. van der Valk,Sonia Tolani,Erik S.G. Stroes,Marit Westerterp,Alan R. Tall	46
18	In Vivo Imaging of Enhanced Leukocyte Accumulation in Atherosclerotic Lesions in Humans 2014 ·Journal of the American College of Cardiology ·Fleur M. van der Valk,Jeffrey Kroon,Wouter V. Potters,Rogier M. Thurlings,Roelof J. Bennink,Hein J. Verberne,Aart J. Nederveen,Max Nieuwdorp,Willem J. M. Mulder,Zahi A. Fayad,Jaap D. van Buul,Erik S.G. Stroes	36
19	Nonpharmacological Lipoprotein Apheresis Reduces Arterial Inflammation in Familial Hypercholesterolemia 2014 ·Journal of the American College of Cardiology ·Diederik F. van Wijk,Barbara Sjouke,Amparo L. Figueroa,Hamed Emami,Fleur M. van der Valk,Megan H. MacNabb,Linda Hemphill,Dominik M. Schulte,M. G. Koopman,Mark E. Lobatto,Hein J. Verberne,Zahi A. Fayad,John J.P. Kastelein,Willem J. M. Mulder,G. Kees Hovingh,Ahmed Tawakol,Erik S.G. Stroes	76
20	Novel anti-inflammatory strategies in atherosclerosis 2012 ·Current Opinion in Lipidology ·Fleur M. van der Valk,Diederik F. van Wijk,Erik S.G. Stroes	38

About Fleur M. van der Valk

Fleur M. van der Valk is a scholar working on Immunology and Allergy, Immunology and Rheumatology, having authored 24 papers that have together received 1.6k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (14 papers), Lipoproteins and Cardiovascular Health (9 papers) and Adipokines, Inflammation, and Metabolic Diseases (6 papers). The work is most often cited by research in Immunology (591 citations), Surgery (720 citations) and Endocrinology, Diabetes and Metabolism (242 citations). Fleur M. van der Valk has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Erik S.G. Stroes, Hein J. Verberne, Aart J. Nederveen, Jeffrey Kroon, Max Nieuwdorp, Jan Van den Bossche, Simone L. Verweij, Jaap D. van Buul, Siroon Bekkering and Julian C. van Capelleveen. Their work appears in journals such as Circulation, Journal of the American College of Cardiology and Journal of the American Society of Nephrology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact